Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance

por Nicolescu, Radu Costin Bizga, Maylin, Zoe R., Pérez‐Areales, Francisco Javier, Iegre, Jessica, Pandha, Hardev S., Asim, Mohammad, Spring, David R.
Publicado 2022